ANNA BUCK: Open Payments
NPI 1174278667 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,279 in 58 payments from 17 companies in 2025. Trend: 2023 $1,130 · 2024 $1,901 · 2025 $1,279
Food & beverage: $1,279
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $354 |
| ABBVIE INC. | 7 | $173 |
| Novartis Pharmaceuticals Corporation | 6 | $147 |
| Regeneron Healthcare Solutions, Inc. | 6 | $110 |
| LEO Pharma Inc. | 4 | $83 |
| Incyte Corporation | 4 | $70 |
| Janssen Biotech, Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $37 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $37 |
| ConvaTec Inc. | 1 | $36 |
Products named: DUPIXENT, SKYRIZI, COSENTYX, OPZELURA, ANZUPGO, TREMFYA, INNOVAMATRIX AC, AMELUZ.
Industry payments across TX — which companies pay providers there.
